Author

Bita Mesgarpour

Observed names: B. Mesgarpour, Bita Mesgarpour, Bita MESGARPOUR, Bita Mesgarpour5, Mesgarpour Bita, Mesgarpour, Bita, bita Mesgarpour

Institution: National Institute for Medical Research Development

Observed institutions: Iran University of Medical Sciences, Vienna General Hospital, Ministry of Health and Medical Education, National Institute for Medical Research, National Institute for Medical Research Development, Psychiatry and Psychology Research Center, Digestive Disease Research Institute, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences, Medical University of Vienna

ORCID: 0000-0002-4004-8493

Observed ORCID: 0000-0002-4004-8493

OpenAlex ID: A5023203662

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

2022 · Hongchao Pan, Richard Peto, et al. · The Lancet · 434

PDF

An epidemiological survey of psychiatric disorders in Iran.

2005 · Mohammad-Reza Mohammadi, Haratoon Davidian, et al. · Clinical Practice and Epidemiology in Mental Health · 249

PDF

Acupuncture or acupressure for pain management during labour

2020 · Caroline A Smith, Carmel T Collins, et al. · Cochrane Database of Systematic Reviews · 162

Prevalence of obsessive-compulsive disorder in Iran

2004 · Mohammad Reza Mohammadi, Ahmad Ghanizadeh, et al. · BMC Psychiatry · 116

PDF

Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis

2022 · Hossein Hatami1, Giovanni Sotgiu2, et al. · Jornal Brasileiro de Pneumologia · 54

PDF

l -Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

2017 · Reihaneh Hajizadeh-Zaker, Alireza Ghajar, et al. · Journal of Child and Adolescent Psychopharmacology · 47

Health research system resilience: lesson learned from the COVID-19 crisis

2020 · Bahareh Yazdizadeh, Reza Majdzadeh, et al. · Health Research Policy and Systems · 45

PDF

Selegiline in Comparison with Methylphenidate in Attention Deficit Hyperactivity Disorder Children and Adolescents in a Double-Blind, Randomized Clinical Trial

2004 · Mohammad Reza Mohammadi, Ahmad Ghanizadeh, et al. · Journal of Child and Adolescent Psychopharmacology · 40

Interventions to improve adverse drug reaction reporting: A scoping review

2020 · Malahat Khalili, Bita Mesgarpour, et al. · Pharmacoepidemiology and Drug Safety · 38

L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study

2017 · Somaye Arabzadeh, Maryam Shahhossenie, et al. · Human Psychopharmacology Clinical and Experimental · 38

Prevalence of Mood Disorders in Iran

2006 · Hamid Reza Pouretemad, Hamid Reza Naghavi, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 38

Harms of off-label erythropoiesis-stimulating agents for critically ill people

2017 · Bita Mesgarpour, Benedikt H Heidinger, et al. · Cochrane Database of Systematic Reviews · 36

Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review

2015 · Rishi J. Desai, Kylie J. Thaler, et al. · Arthritis Care & Research · 34

Prevalence of social phobia and its comorbidity with psychiatric disorders in Iran

2006 · Mohammad-Reza Mohammadi, Ahmad Ghanizadeh, et al. · Depression and Anxiety · 34

PDF

Prevalence of psychiatric disorders in Iran: A systematic review

2007 · Ali Farhoudian, Vandad Sharifi, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 32

Extended‐release opioids in the management of cancer pain: A systematic review of efficacy and safety

2013 · B. Mesgarpour, U. Griebler, et al. · European Journal of Pain · 31

PDF

Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial

2020 · Ehsan Moazen-Zadeh, Samaneh Bayanati, et al. · Journal of Psychopharmacology · 30

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis

2013 · Bita Mesgarpour, Benedikt H. Heidinger, et al. · Intensive Care Medicine · 27

How the US Sanctions Are Affecting the Health Research System in Iran?

2021 · Mohammad Dehghani, Bita Mesgarpour, et al. · Archives of Iranian Medicine · 26

PDF

Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial.

2017 · Sophia Esalatmanesh, Mojtaba Biuseh, et al. · PubMed Central · 24

PDF

Assessing research misconduct in Iran: a perspective from Iranian medical faculty members

2021 · Erfan Shamsoddin, Zahra Torkashvand-Khah, et al. · BMC Medical Ethics · 21

PDF

Herbal Medicine in Iran

2007 · Hamid‐Reza Adhami, Bita Mesgarpour, et al. · 19

Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran

2022 · Pooran Mohsenzadeh, Ali Ardekani, et al. · BMC Cardiovascular Disorders · 17

PDF

Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study

2017 · Farzin Rezaei, Bita Mesgarpour, et al. · Human Psychopharmacology Clinical and Experimental · 17

Estimating the Prevalence of Hepatitis B Virus Infection and Exposure Among General Population in Iran

2017 · Behzad Hajarizadeh, Bita Mesgarpour, et al. · Hepatitis Monthly · 15

PDF

Works count: 103

Citation count: 1,852

H-index: 21

I10-index: 33